These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 29885308
1. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study. Cotten SW, Shajani-Yi Z, Cervinski MA, Voorhees T, Tuchman SA, Korpi-Steiner N. Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308 [Abstract] [Full Text] [Related]
2. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines. Morales-García LJ, Pacheco-Delgado MS. Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349 [Abstract] [Full Text] [Related]
3. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications. Mohammed N, Chandran PA, Kandregula M, Mattaparthi RD, Gundeti S, Volturi J, Darapuneni R, Raju SB, Dattatreya PS. Asian Pac J Cancer Prev; 2016 Jun; 17(5):2605-10. PubMed ID: 27268638 [Abstract] [Full Text] [Related]
4. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool. Campbell JP, Heaney JL, Shemar M, Baldwin D, Griffin AE, Oldridge E, Goodall M, Afzal Z, Plant T, Cobbold M, Jefferis R, Jacobs JF, Hand C, Drayson MT. Clin Chem Lab Med; 2017 Mar 01; 55(3):424-434. PubMed ID: 27505089 [Abstract] [Full Text] [Related]
5. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Clin Chem; 2002 Sep 01; 48(9):1437-44. PubMed ID: 12194920 [Abstract] [Full Text] [Related]
6. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population. Liang YF, Chen WM, Wang QT, Zhai YH, Yang YJ, Liu JY, Levoguer A, Sun WH. Clin Lab; 2014 Sep 01; 60(2):193-8. PubMed ID: 24660530 [Abstract] [Full Text] [Related]
7. Serum Free Light Chain Reference Intervals in a Local Population in Spain using the Optilite Analyser. Rocamonde L, Hermida FJ. Clin Lab; 2023 Jan 01; 69(1):. PubMed ID: 36649521 [Abstract] [Full Text] [Related]
8. Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform. Muluhngwi P, Sharp CN, Pozzi N, Elin RJ, Jortani SA. J Appl Lab Med; 2019 Nov 01; 4(3):323-330. PubMed ID: 31659070 [Abstract] [Full Text] [Related]
9. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell JP, Cobbold M, Wang Y, Goodall M, Bonney SL, Chamba A, Birtwistle J, Plant T, Afzal Z, Jefferis R, Drayson MT. J Immunol Methods; 2013 May 31; 391(1-2):1-13. PubMed ID: 23388695 [Abstract] [Full Text] [Related]
10. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population. Abadie JM, Bankson DD. Ann Clin Lab Sci; 2006 May 31; 36(2):157-62. PubMed ID: 16682511 [Abstract] [Full Text] [Related]
11. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use. Hansen CT, Münster AM, Nielsen L, Pedersen P, Abildgaard N. Eur J Haematol; 2012 Dec 31; 89(6):458-68. PubMed ID: 22998393 [Abstract] [Full Text] [Related]
12. Expression and diagnostic value of serum free light chain in lung cancer. Xiao X, Zheng L, Zeng H, Chen D, Liu L, Dong C, Zhang Y. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jun 28; 49(6):914-920. PubMed ID: 39311787 [Abstract] [Full Text] [Related]
13. Serum free light chains: diagnostic and prognostic value in multiple myeloma. Sthaneshwar P, Nadarajan V, Maniam JA, Nordin N, Gin Gin G. Clin Chem Lab Med; 2009 Jun 28; 47(9):1101-7. PubMed ID: 19728852 [Abstract] [Full Text] [Related]
14. Effects of Long-Term Storage on Serum Free Light Chain Stability. Hörber S, Klein R, Peter A. Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115238 [Abstract] [Full Text] [Related]
15. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof]. Sui WW, Yao HJ, Wang YF, Wang L, Zhang K, Xu Y, Qiu LG. Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3158-60. PubMed ID: 18269880 [Abstract] [Full Text] [Related]
16. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY, Suh JT, Lee HJ, Yoon HJ, Lee WI. Ann Hematol; 2005 Sep 27; 84(9):588-93. PubMed ID: 15883850 [Abstract] [Full Text] [Related]
17. Analytical validation of new ELISAs for the quantitation of polyclonal free light chains and comparison to existing assays for healthy and patient samples. Heaney JLJ, Campbell JP, Goodall M, Plant T, Shemar M, Hand C, Drayson MT. J Immunol Methods; 2020 Mar 27; 478():112713. PubMed ID: 31783021 [Abstract] [Full Text] [Related]
18. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA. Clin Chem; 2005 May 27; 51(5):878-81. PubMed ID: 15774572 [Abstract] [Full Text] [Related]
19. Serum free light chain reference values: a critical approach. Altinier S, Seguso M, Zaninotto M, Varagnolo M, Adami F, Angeli P, Plebani M. Clin Biochem; 2013 May 27; 46(7-8):691-3. PubMed ID: 23384536 [Abstract] [Full Text] [Related]
20. Assessment of serum free light chain levels in healthy adults immediately after marathon running. Campbell JP, Eijsvogels TM, Wang Y, Hopman MT, Jacobs JF. Clin Chem Lab Med; 2016 Mar 27; 54(3):459-65. PubMed ID: 26351935 [Abstract] [Full Text] [Related] Page: [Next] [New Search]